Resources

User research in low-resource primary health care settings to inform decisions, and better understand and define user and health system constraints related to integrating smartphones and multimodal devices into integrated management of childhood illness (IMCI) practices.

This fact sheet provides an overview of the novel oral polio vaccine (nOPV) program—a consortium of PATH and partners that are working to advance novel vaccine candidates that will enable complete eradication and minimize the risk of polio resurgence.

This spreadsheet provides publicly available information on clinical trials of respiratory syncytial virus (RSV) candidate vaccines and monoclonal antibodies intended for prevention.Sources of information for these trials are clinicaltrials.gov; who.int/clinical-trials-registry-platform; clinicaltrialsregister.eu; and anzctr.org.au, which includes clinical trial registries from 17 countries.Some information is also obtained through contact with investigators, sponsors, and funders of vaccine trials. This spreadsheet pairs with the RSV Vaccine and mAb Snapshot, which provides a summary of the RSV vaccine and mAb candidates in development worldwide.

This report present’s PATH’s Living Labs synthesis of insights including gaps, trends, findings, and recommendations for primary healthcare in Ghana, Kenya, Nigeria, Rwanda, Tanzania, and Zambia conducted between January and March 2023.

From our collaborative efforts with various stakeholders to address their challenges, PATH's Living Labs has compiled valuable lessons learned and actionable recommendations for adoption and ownership by health care workers, ministries of health, and other stakeholders.